The Senior Research Associate will synthesize mRNA, characterize its quality, and improve RNA processes while collaborating with team members. This role requires strong organizational and analytical skills, and supports gene editing initiatives.

The Associate Director, Safety Scientist is responsible for proactive safety monitoring, signal detection, drafting safety plans, and collaborating across functions for safety governance in drug development and post-marketing processes.

The National Account Director will shape and execute the market access strategy with national and large regional payers for gene editing therapy launch, build key relationships, and ensure optimal access to novel treatments.

The Associate Director will oversee commercial data operations, partner with IT, and support sales execution through data analytics and system management.

The Senior Corporate Counsel, Commercial provides legal support for the launch of a gene editing therapy, advising on regulatory compliance, strategic initiatives, and enhancing Intellia's compliance program.

The Executive Assistant will manage calendars, coordinate meetings and travel, support key projects, and ensure effective communication for commercial leadership.

Lead and mentor a team to activate treatment sites for CRISPR therapy, ensuring patient access and operational excellence, while collaborating with cross-functional teams.

The Strategic Accounts Director will lead a team to enable and optimize treatment sites for a CRISPR therapy, overseeing strategy, team development, performance metrics, and cross-functional collaboration.

The Senior Manager of Commercial Accounting will lead financial processes to support the transition of Intellia to a commercial organization, ensuring compliance and operational excellence in revenue recognition and order-to-cash systems.

The Associate Director will support pricing, contracting, and market access strategies for CRISPR therapies, focusing on operational activities, contract management, and revenue operations in a collaborative environment.

Oversee a team applying genomic tools for gene editing therapies, managing projects, budgets, and collaborations to ensure innovative advancements.

Lead the development and management of the Integrated Launch Plan, facilitate meetings, manage documentation, and ensure successful product commercialization for Intellia's first launch.

Lead the global Pharmacovigilance quality function, ensuring compliance across safety activities, managing audits, and mentoring teams for regulatory excellence.

The National Account Director will lead engagement with Medicaid and government payers, shaping access strategies for gene editing therapies and managing relationships with key stakeholders to ensure optimal coverage and reimbursement.

Responsible for the integrity of the General Ledger and the month-end close cycle, performing reconciliations, managing Fixed Assets, and ensuring compliance with US GAAP and SOX.

The Associate Director Data Architect is responsible for managing enterprise integrations, establishing standards, driving automation, and ensuring secure, scalable connectivity across IT systems.

Lead the development of Commercial Operations, establish strategic objectives, manage budget, and drive cross-functional collaboration in the commercialization of gene editing therapies.

The Senior Manager, Oracle Financials Specialist leads the optimization of Oracle Fusion applications, manages system integrity, oversees compliance, and drives cross-functional partnerships to ensure business objectives are met in a regulated life sciences environment.